Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 522

    1.

    Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression.

    Carlson CJ, Koterski S, Sciotti RJ, Poccard GB, Rondinone CM.

    Diabetes. 2003 Mar;52(3):634-41.PMID: 12606502 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes.

    Sweeney G, Somwar R, Ramlal T, Volchuk A, Ueyama A, Klip A.

    J Biol Chem. 1999 Apr 9;274(15):10071-8.PMID: 10187787 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Three mitogen-activated protein kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes.

    Fujishiro M, Gotoh Y, Katagiri H, Sakoda H, Ogihara T, Anai M, Onishi Y, Ono H, Abe M, Shojima N, Fukushima Y, Kikuchi M, Oka Y, Asano T.

    Mol Endocrinol. 2003 Mar;17(3):487-97. Epub 2002 Dec 5.PMID: 12554784 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Arsenite stimulated glucose transport in 3T3-L1 adipocytes involves both Glut4 translocation and p38 MAPK activity.

    Bazuine M, Ouwens DM, Gomes de Mesquita DS, Maassen JA.

    Eur J Biochem. 2003 Oct;270(19):3891-903.PMID: 14511371 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effects of losartan in combination with or without exercise on insulin resistance in Otsuka Long-Evans Tokushima Fatty rats.

    Ishizawa K, Yoshizumi M, Tsuchiya K, Takishita E, Nakaya Y, Kishi K, Ebina Y, Houchi H, Minakuchi K, Tamaki T.

    Eur J Pharmacol. 2001 Nov 2;430(2-3):359-67.PMID: 11711055 [PubMed - indexed for MEDLINE]Related articles

    7.

    MKK6/3 and p38 MAPK pathway activation is not necessary for insulin-induced glucose uptake but regulates glucose transporter expression.

    Fujishiro M, Gotoh Y, Katagiri H, Sakoda H, Ogihara T, Anai M, Onishi Y, Ono H, Funaki M, Inukai K, Fukushima Y, Kikuchi M, Oka Y, Asano T.

    J Biol Chem. 2001 Jun 8;276(23):19800-6. Epub 2001 Feb 27.PMID: 11279172 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Tumor necrosis factor alpha-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes.

    Engelman JA, Berg AH, Lewis RY, Lisanti MP, Scherer PE.

    Mol Endocrinol. 2000 Oct;14(10):1557-69.PMID: 11043572 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes.

    Gao Z, Zhang X, Zuberi A, Hwang D, Quon MJ, Lefevre M, Ye J.

    Mol Endocrinol. 2004 Aug;18(8):2024-34. Epub 2004 May 13.PMID: 15143153 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Involvement of the actin network in insulin signalling.

    Tsakiridis T, Wang Q, Taha C, Grinstein S, Downey G, Klip A.

    Soc Gen Physiol Ser. 1997;52:257-71.PMID: 9210235 [PubMed - indexed for MEDLINE]Related articles

    12.

    Altered regulation of insulin signaling components in adipocytes of insulin-resistant type II diabetic Goto-Kakizaki rats.

    Begum N, Ragolia L.

    Metabolism. 1998 Jan;47(1):54-62.PMID: 9440478 [PubMed - indexed for MEDLINE]Related articles

    13.

    Decreased Akt kinase activity and insulin resistance in C57BL/KsJ-Leprdb/db mice.

    Shao J, Yamashita H, Qiao L, Friedman JE.

    J Endocrinol. 2000 Oct;167(1):107-15.PMID: 11018758 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.

    Mur C, Valverde AM, Kahn CR, Benito M.

    Diabetes. 2002 Mar;51(3):743-54.PMID: 11872675 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    GLUT4 translocation precedes the stimulation of glucose uptake by insulin in muscle cells: potential activation of GLUT4 via p38 mitogen-activated protein kinase.

    Somwar R, Kim DY, Sweeney G, Huang C, Niu W, Lador C, Ramlal T, Klip A.

    Biochem J. 2001 Nov 1;359(Pt 3):639-49.PMID: 11672439 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    High leptin levels acutely inhibit insulin-stimulated glucose uptake without affecting glucose transporter 4 translocation in l6 rat skeletal muscle cells.

    Sweeney G, Keen J, Somwar R, Konrad D, Garg R, Klip A.

    Endocrinology. 2001 Nov;142(11):4806-12.PMID: 11606447 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Reduced glucose uptake precedes insulin signaling defects in adipocytes from heterozygous GLUT4 knockout mice.

    Li J, Houseknecht KL, Stenbit AE, Katz EB, Charron MJ.

    FASEB J. 2000 Jun;14(9):1117-25.PMID: 10834933 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes.

    Ishibashi KI, Imamura T, Sharma PM, Huang J, Ugi S, Olefsky JM.

    J Clin Invest. 2001 May;107(9):1193-202.PMID: 11342583 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Insulin activates p38 mitogen-activated protein (MAP) kinase via a MAP kinase kinase (MKK) 3/MKK 6 pathway in vascular smooth muscle cells.

    Igarashi M, Yamaguchi H, Hirata A, Daimon M, Tominaga M, Kato T.

    Eur J Clin Invest. 2000 Aug;30(8):668-77.PMID: 10964158 [PubMed - indexed for MEDLINE]Related articles

    20.

    Supplemental Content

    Find related data